John Koreth, Dana-Farber Cancer Institute (IMAGE) Dana-Farber Cancer Institute Caption A study by John Koreth shows a novel drug regimen can improve stem cell transplantation outcomes. Credit Dana-Farber Cancer Institute Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.